Home › High Blood Pressure › Illinois › Springfield
High Blood Pressure clinical trials in Springfield, IL
3 studies for High Blood Pressure are looking for participants at sites in and around Springfield (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Springfield
Global Paradise System US Post Approval Study
RecruitingObservational study
- Southern Illinois University, Memorial Medical Center, Springfield
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Recruiting
- St. John's Prairie Heart, Springfield
- Southern Illinois University, School of Medicine, Springfield
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL21 studies
- Boston, MA21 studies
- Dallas, TX15 studies
- Nashville, TN14 studies
- Birmingham, AL12 studies
- Houston, TX11 studies
- Atlanta, GA10 studies
- Durham, NC10 studies
- Tucson, AZ10 studies
- Rochester, MN9 studies
- Philadelphia, PA9 studies
- Miami, FL9 studies
Other studies in Springfield
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer13 studies
- Colorectal Cancer9 studies
- Breast Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Kidney Cancer (Renal Cell Carcinoma)6 studies
- Bladder Cancer6 studies
- Prostate Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Cancer (all types)5 studies
- Pancreatic Cancer5 studies
- Melanoma5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.